Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07295275

Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection

Sponsor: West China Hospital

View on ClinicalTrials.gov

Summary

This multicenter, ambispective cohort study evaluates the safety and efficacy of trans-arterial Indocyanine Green (ICG) fluorescence-guided laparoscopic liver watershed resection for Hepatocellular Carcinoma (HCC). The study aims to compare the outcomes of the trans-arterial ICG staining approach versus the conventional trans-portal (portal vein) ICG staining approach.

Official title: Safety and Efficacy of Trans-arterial Versus Trans-portal ICG Fluorescence-Guided Laparoscopic Liver Watershed Resection: A Multicenter, Ambispective Cohort Study

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

OBSERVATIONAL

Enrollment

200

Start Date

2026-03-01

Completion Date

2028-09-01

Last Updated

2026-03-03

Healthy Volunteers

No

Conditions

Interventions

PROCEDURE

Laparoscopic Anatomical Liver Resection (guided by transarterial injection of ICG)

Laparoscopic liver resection using ICG fluorescence imaging for tumor and liver segment visualization. Comparison lies in the route of ICG administration (Arterial vs. Portal).

Locations (3)

Beijing Tsinghua Changgung Hospital

Beijing, Beijing Municipality, China

Xuzhou Central Hospital

Xuzhou, Jiangsu, China

West China Hospital

Chengdu, Sichuan, China